BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 20489418)

  • 1. The global burden of diabetes and its complications: an emerging pandemic.
    van Dieren S; Beulens JW; van der Schouw YT; Grobbee DE; Neal B
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S3-8. PubMed ID: 20489418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Type-2 diabetes mellitus as a cause of disability].
    Piechota G; Małkiewicz J; Karwat ID
    Przegl Epidemiol; 2004; 58(4):677-82. PubMed ID: 15810510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study.
    Ringborg A; Lindgren P; Martinell M; Yin DD; Schön S; Stålhammar J
    Diabet Med; 2008 Oct; 25(10):1178-86. PubMed ID: 19046196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.
    Larrañaga I; Arteagoitia JM; Rodriguez JL; Gonzalez F; Esnaola S; Piniés JA;
    Diabet Med; 2005 Aug; 22(8):1047-53. PubMed ID: 16026371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort.
    Song SH; Hardisty CA
    QJM; 2009 Nov; 102(11):799-806. PubMed ID: 19734298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiological features of diabetes-related complications].
    Simon D; Coutant R
    Rev Prat; 2007 Sep; 57(13):1411-22. PubMed ID: 18018540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular complications of diabetes mellitus in sub-Saharan Africa.
    Kengne AP; Amoah AG; Mbanya JC
    Circulation; 2005 Dec; 112(23):3592-601. PubMed ID: 16330701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Swedish cost burden of overweight and obesity--evaluated with the PAR approach and a statistical modelling approach.
    Odegaard K; Borg S; Persson U; Svensson M
    Int J Pediatr Obes; 2008; 3 Suppl 1():51-7. PubMed ID: 18278633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes in Japan: a review of disease burden and approaches to treatment.
    Neville SE; Boye KS; Montgomery WS; Iwamoto K; Okamura M; Hayes RP
    Diabetes Metab Res Rev; 2009 Nov; 25(8):705-16. PubMed ID: 19795421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
    Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
    Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of insulin resistance.
    Turtle JR
    Int J Clin Pract Suppl; 2000 Oct; (113):23-8. PubMed ID: 11965827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of treating type 2 diabetes (CODEIRE).
    Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
    Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of diabetes and its complications: trends and implications for intervention.
    Chaturvedi N
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S3-12. PubMed ID: 17343954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG
    World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.